Skip to main content
. 2005 Jul 12;93(3):279–286. doi: 10.1038/sj.bjc.6602696

Table 1. Patient characteristics by treatment.

  C (n=59) S (n=60) All patients (n=119)
Age (years)      
 Median 60 58 59
 Range 35–73 27–75 27–75
       
Sex (%)      
 Male 51 (86) 53 (88) 104 (87)
 Female 8 (14) 7 (12) 15 (13)
       
Race (%)      
 Chinese 45 (76) 50 (84) 95 (80)
 Indian 8 (14) 5 (8) 13 (11)
 Malay 6 (10) 5 (8) 11 (9)
       
Site of disease (%)      
 Oral cavity 19 (32) 13 (22) 32 (27)
 Oropharynx 12 (20) 13 (22) 25 (21)
 Hypopharynx 7 (12) 7 (12) 14 (12)
 Supraglottis 13 (22) 14 (23) 27 (23)
 Glottis 5 (9) 5 (8) 10 (8)
 Subglottis 0 (0) 1 (1) 1 (1)
 Maxillary sinus 3 (5) 7 (12) 10 (8)
       
Tumour status (%)      
 T1 0 (0) 5 (8) 5 (4)
 T2 9 (15) 8 (13) 17 (14)
 T3 16 (27) 15 (25) 31 (26)
 T4 34 (58) 32 (54) 66 (56)
       
Nodal status (%)      
 N0 19 (32) 17 (28) 36 (30)
 N1 15 (25) 7 (12) 22 (19)
 N2 24 (41) 31 (52) 55 (46)
 N3 1 (2) 5 (8) 6 (5)
       
TNM staging (%)      
 Stage III 12 (20) 12 (20) 24 (20)
 Stage IVA 46 (78) 43 (72) 89 (75)
 Stage IVB 1 (2) 5 (8) 6 (5)